Live from the NIH registry
Studies recruiting near Boise right now
Top 25 of 266 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
St. Alphonsus Regional Medical Center — Boise, Idaho (1.6 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Boise Kidney — Boise, Idaho (1.6 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Refractory Differentiated Thyroid Gland Carcinoma
Phase 3
Interventional 264 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Boise, Idaho (1.6 mi)
· Sponsor: Sameek Roychowdhury
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Boise, Idaho Investigative Site 10073 — Boise, Idaho (1.6 mi)
· Sponsor: Colorado Prevention Center
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Phase 3
Interventional 250 participants sought
St. Luke's Clinic - Rheumatology — Boise, Idaho (1.6 mi)
· Sponsor: Vor Biopharma
HBOT Effects on First Responders' Cognition and Well-Being
Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder
Phase 2
Interventional 54 participants sought
Summit Hyperbarics and Wellness — Boise, Idaho (1.6 mi)
· Sponsor: Summit Hyperbarics and Wellness
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma
Phase 2
Interventional 156 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Asr, Llc — Boise, Idaho (1.6 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (17.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi)
· Sponsor: NRG Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Saint Luke's Cancer Institute - Boise — Boise, Idaho (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Reducing Crises and Suicide Within the Idaho Army National Guard
Crisis Response Plan, Crisis Intervention
N/A
Interventional 450 participants sought
Idaho Army National Guard — Boise, Idaho (1.6 mi)
· Sponsor: University of Rochester
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Saint Alphonsus Cancer Care Center-Nampa — Nampa, Idaho (17.2 mi)
· Sponsor: National Cancer Institute (NCI)
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Boise VA Medical Center — Boise, Idaho (1.6 mi)
· Sponsor: Ferring Pharmaceuticals
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Saint Alphonsus Cancer Care Center-Boise — Boise, Idaho (1.6 mi)
· Sponsor: National Cancer Institute (NCI)
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Growth Hormone Deficiency
N/A
Observational 900 participants sought
Ascendis Investigational Site — Boise, Idaho (1.6 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
St. Luke's Idaho Cardiology Associates — Meridian, Idaho (8.1 mi)
· Sponsor: Novo Nordisk A/S
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Saint Alphonsus Regional Medical Center ( Site 0067) — Boise, Idaho (1.6 mi)
· Sponsor: Merck Sharp & Dohme LLC